prostate-report.org

New cancer drug will prolong lives

Vancouver researchers of the Prostate Centre at Vancouver General Hospital have developed a new cancer-fighting drug that will prolong the life of patients with advanced prostate cancer, doubling their life expectancy compared with a decade ago.
The drug, called OGX-011,  works by inhibiting the production of a gene protein called clusterin that protects cancer cells from cancer treatments, such as radiation and chemotherapy

A report on the findings will be published in the October edition of the Journal of Clinical Oncology.